Strategic Blueprint’s Medpace MEDP Stock Holding History

Strategic Blueprint’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-100	Closed	-$18K	–	939
2021 Q2	$18K	Buy	+100	New	+$17.3K	﹤0.01%	837

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Strategic Blueprint's MEDP Position: Q3 2021 in Review

Strategic Blueprint sold out of Medpace (MEDP) in Q3 2021, closing a stake of 100 shares — an estimated $18K sold.

Strategic Blueprint first reported a position in MEDP in Q2 2021 and held it in 1 quarter. The position peaked at $18K in Q2 2021. 337 funds tracked by Wall St. Rank hold MEDP as of Q3 2021.

Strategic Blueprint reported no remaining Medpace position as of Q3 2021 after selling out during the quarter.
Strategic Blueprint sold 100 Medpace shares in Q3 2021, an estimated $18K.
Strategic Blueprint first reported a position in Medpace in Q2 2021 and held it in 1 quarter.
Strategic Blueprint's Medpace position peaked at $18K in Q2 2021.
337 funds tracked by Wall St. Rank held Medpace as of Q3 2021.

Based on Strategic Blueprint's 13F filing for Q3 2021, filed 12 Nov 2021.